
Strategic Report / Directors’ Report / Auditor’s Report / Financial Statements
Our GTP framework focuses on four key pillars: Customer
Obsession, World Class Product, Sales Excellence and
Operational Agility. 2024 was focused on accelerating
implementation of key initiatives such as: getting closer to our
clients, putting Artificial Intelligence at the centre of how we
operate and investing in accretive M&A, all underpinned by
investment in people and organisational transformation.
The financial results for 2024 do not reflect the impact of
some of the initiatives that we have launched in the year, as
we look more to the medium term to see noticeable benefits.
However, we have set some of the foundational areas of
the transformation journey and with the four completed
acquisitions and organic growth, we are scaling towards the
£500m revenue target as set last year for the end of 2026.
Board Succession and Sustainability
The Board continues to place utmost importance on having the
governance and structures in place to fully support the Executive
Directors and Senior Leadership Team to succeed and ultimately
maximise shareholder return. During 2024, the Board focused on
the launch of the GTP and that the right leadership is in place to
ensure the programme is set up for success.
Annette Barnes and Andrew Day were appointed as Non-
Executive Directors of GlobalData in February 2017. Annette
serves as Chair of the Company’s Remuneration Committee and
is also the Company’s Senior Independent Director. Given that
their terms as recommended by the UK Corporate Governance
Code will expire in January 2026, the Company will shortly
be commencing a process to be led by myself to identify their
successors. It is intended that Annette’s successor as Chair of
the Remuneration Committee will be appointed in good time
during 2025 to ensure an orderly handover of Remuneration
Committee responsibilities. The Board will seek Annette’s and
Andrew’s re-elections at the 2025 AGM.
I joined the Board as Non-Executive Director on 24 February
2016 and was appointed as Chair on 20 April 2021 and
therefore, as prescribed by provision 19 of the UK Corporate
Governance Code, my term should have expired on 24 February
2025. However, following a review led by the Senior Independent
Director, and as permitted by the UK Corporate Governance
Code, the Board recommended a limited extension of my term
as Chair, which I have accepted. The extension will facilitate
stability, consistency and governance across a large programme
of transformation (including succession planning for the Board
and Remuneration Committee) and the Board believe that this
is in the best interests of the Company and all its shareholders.
Therefore, I will be seeking re-election at the 2025 AGM.
We continue to improve and evolve our climate-related
governance and reporting efforts, which includes disclosure of
our Non-Financial and Sustainability Information Statement
on page 46. Our near-term reduction and Net Zero targets
were validated by the Science Based Targets initiative (SBTi)
during 2024, confirming our robust approach to reducing GHG
emissions, and with independent experts, we have created
a roadmap of reductions to meet those targets. Our climate
discussions will continue in 2025, which will encompass the
review, monitoring, and discussion of climate-related financial
risks and opportunities as well as wider sustainability matters.
Looking Ahead
As we move into 2025, the Board remains confident in
our strategic direction and the opportunities ahead. The
foundations we have laid through the Growth Transformation
Plan position us well to capture the growing demand for
data-driven insights across all our market sectors.
We will continue to focus on accelerating organic growth,
exploring strategic acquisition opportunities, and delivering
increased value to our shareholders. The market for data and
analytics solutions continues to expand, and we are well-
positioned to capitalise on this growth.
We have announced our intention to move to a premium listing
on the London Stock Exchange (Main Market). We believe that
this move will provide the Group with access to a wider pool of UK
and international capital that will support our long-term growth
ambitions and also reflect the progress that the Group has made
in its scale, business model and governance arrangements.
On behalf of the Board, I would like to thank our shareholders
for their continued support, our clients for their trust in our
service offering, and our employees for their unwavering
commitment to excellence. The progress we have made in
2024 gives us confidence in our ability to deliver sustainable
growth and value creation in the years ahead.
Dividend
As noted in our half year results statement (published 31 July
2024), following on from the completion of the Healthcare
transaction and the strategy to focus more capital towards
M&A, we have rebased the dividend for the period from 1 July
2024. Therefore, we are pleased to propose a final dividend of
1.0 pence per share (2023: 3.2 pence per share), to be paid
on 2 May 2025 to shareholders on the register at the close of
business on 21 March 2025. The ex-dividend date will be on
20March 2025. The proposed final dividend means that the
total dividend for the year is 2.5 pence per share (2023: 4.6
pence).
Murray Legg
Chair
10 March 2025
ANNUAL REPORT AND ACCOUNTS 2024
9